Guardant Health, Inc. reported $1.18B of revenue over the trailing twelve months, +43% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.18B (to Q2 2026). Net income: −$453M, trailing twelve months to Q2 2026. Free cash flow: −$241M, trailing twelve months to Q2 2026. Operating margin: −40%, trailing twelve months to Q2 2026.

GHGuardant Health, Inc.

Healthcare

$167.39+183% 1Y

$167.39

$57.6752 weeks$187.33

GH as reported

Guardant Health, Inc. reported $1.18B of revenue over the trailing twelve months, +43% on the year before. 10 reported series are charted on this page, each one as filed.

$1.18B

Revenue, trailing twelve months · to Q2 2026 · +43% against the twelve months before

Net income: −$453M
Net income · +9.6% year on year · trailing twelve months to Q2 2026
Free cash flow: −$241M
Free cash flow · −11% year on year · trailing twelve months to Q2 2026
Operating margin: −40%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for GH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.18B	+43%	Q2 2026
Net income	−$453M	+9.6%	Q2 2026
EPS	−$3.49	+4.2%	Q2 2026
Gross margin	65%	n/a	Q2 2026
Operating margin	−40%	n/a	Q2 2026
Net margin	−38%	n/a	Q2 2026
ROE	244%	n/a	Q2 2026
ROA	−25%	n/a	Q2 2026
ROIC	−172%	n/a	Q2 2026
Free cash flow	−$241M	−11%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.